new antibiotic for traveler's diarrhea called Xifaxan (zuh-FAX-in, rifaximin)

July 2004

You'll soon see a new antibiotic for traveler's diarrhea called Xifaxan (zuh-FAX-in, rifaximin).

It's a derivative of rifampin. It's for treating traveler's diarrhea caused by noninvasive E. coli...the most common cause.

Xifaxan is NOT absorbed systemically. This means fewer side effects...drug interactions...or resistance.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote